| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 304.34B | 299.29B | 296.52B | 285.14B | 260.12B |
| Gross Profit | 46.34B | 39.94B | 39.05B | 29.07B | 27.38B |
| EBITDA | 36.01B | 31.96B | 29.81B | 22.25B | 20.42B |
| Net Income | 11.25B | 7.82B | 6.59B | 1.61B | 1.09B |
Balance Sheet | |||||
| Total Assets | 398.84B | 400.06B | 443.11B | 385.45B | 364.40B |
| Cash, Cash Equivalents and Short-Term Investments | 33.57B | 36.27B | 46.55B | 47.53B | 32.87B |
| Total Debt | 47.47B | 67.42B | 76.54B | 89.49B | 69.35B |
| Total Liabilities | 149.91B | 156.66B | 181.10B | 171.12B | 151.92B |
| Stockholders Equity | 236.26B | 231.94B | 250.97B | 203.76B | 201.55B |
Cash Flow | |||||
| Free Cash Flow | 50.36B | 3.68B | 14.51B | -2.95B | -10.81B |
| Operating Cash Flow | 65.03B | 25.35B | 33.82B | 13.03B | 5.21B |
| Investing Cash Flow | -17.29B | -17.92B | -18.89B | -15.96B | -15.54B |
| Financing Cash Flow | -51.64B | -17.67B | -16.28B | 17.00B | -11.99B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥763.03B | 9.48 | 10.78% | 4.68% | -4.09% | -0.76% | |
74 Outperform | ¥377.80B | 9.05 | 6.16% | 2.99% | -0.98% | -45.90% | |
74 Outperform | ¥204.69B | 14.50 | 6.87% | 5.25% | -3.16% | 45.15% | |
71 Outperform | ¥184.70B | 16.46 | 5.06% | 1.80% | 1.69% | 71.95% | |
67 Neutral | ¥3.06T | 12.26 | -0.26% | 4.53% | 7.07% | -111.21% | |
64 Neutral | ¥1.03T | 9.28 | 2.09% | 4.59% | -8.42% | -60.88% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |